HMGN — Hemagen Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.96m
- $4.04m
Annual cashflow statement for Hemagen Diagnostics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2008 September 30th | 2009 September 30th | 2010 September 30th | 2011 September 30th | 2012 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.427 | -0.808 | -0.156 | -0.88 | -0.907 |
| Depreciation | |||||
| Non-Cash Items | -0.73 | 0.341 | 0.006 | 0.087 | 0.097 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.46 | 0.328 | -0.197 | 0.27 | 0.288 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.265 | 0.018 | -0.183 | -0.337 | -0.359 |
| Capital Expenditures | -0.368 | -0.115 | -0.074 | -0.056 | -0.091 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.184 | 0.262 | 0.251 | 0.213 | 0.035 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.184 | 0.147 | 0.177 | 0.156 | -0.056 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.039 | -0.223 | -0.031 | 0.271 | 0.307 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.092 | 0.058 | -0.005 | 0.062 | -0.147 |